FMP
Berenberg Bank Raised Teladoc Health Price Target to $230 From $227
Sep 21, 2021 11:03 PM - Davit Kirakosyan(Last modified: Dec 19, 2023 5:49 PM)
Image credit: FMP
Analysts at Berenberg Bank provided an update on Teladoc Health, Inc. (NYSE:TDOC) following their recent call with the management of the company, who remained positive on the trends supporting Teladoc Health’s growth.
Following the fireside chat with Jason Gorevic (CEO), Mala Murthy (CFO), and David Sides (COO), the analysts believe investors continue to overlook rising utilization of members and potential PMPM upside that should follow, noting that Primary360 represents a new growth driver for the company in 2022 and should support a higher PMPM.
As a result of the meeting, the brokerage raised its price target on the company’s shares to $230 from $227, reiterating its buy rating. The company’s shares were trading more than 3% higher Tuesday afternoon.
Analysts at Berenberg Bank mentioned they believe the company will continue to benefit from the rise of telehealth, accelerated by the COVID-19 pandemic, and its market leadership position in healthcare tech is solidified by the strategic Livongo merger.
Other Blogs
Oct 31, 2023 8:03 AM - Parth Sanghvi
FCFF vs FCFE: What's the Difference?
Free cash flow to the firm (FCFF) and free cash flow to equity (FCFE) are two of the most important metrics used in financial modeling. Both metrics measure the amount of cash that is available to a company's shareholders and creditors, but there is a key difference between the two. FCFF measures...
Nov 25, 2023 6:39 AM - Parth Sanghvi
DCF Valuation vs. Comparable Companies Analysis: Choosing the Right Valuation Method
Choosing the Right Valuation Method: DCF vs. Comparable Companies Analysis Introduction: Valuation methods play a pivotal role in determining the fair value of a company, aiding investors in making informed investment decisions. Two commonly used methods, DCF Valuation and Comparable Companies A...
Dec 23, 2023 2:19 AM - Parth Sanghvi
Understanding the Limitations of DCF Analysis: A Guide to Overcoming Challenges
Introduction: Discounted Cash Flow (DCF) analysis stands as a cornerstone in valuing investments, yet its efficacy is contingent upon various assumptions and methodologies. While a powerful tool, DCF analysis comes with inherent limitations and challenges that investors must acknowledge to make i...
